Free Trial
NYSEAMERICAN:SYN

Synthetic Biologics (SYN) Stock Price, News & Analysis

Synthetic Biologics logo

About Synthetic Biologics Stock (NYSEAMERICAN:SYN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
57,700 shs
Average Volume
197,338 shs
Market Capitalization
$16.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SYN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Synthetic Biologics and its competitors with MarketBeat's FREE daily newsletter.

SYN Stock News Headlines

Banks aren’t ready for this altcoin—are you?
Want to see why we believe this could be the next evolution of financial infrastructure? The old financial system is showing cracks—and this altcoin might be ready to take its place
See More Headlines

SYN Stock Analysis - Frequently Asked Questions

Synthetic Biologics, Inc. (NYSEAMERICAN:SYN) issued its quarterly earnings data on Tuesday, November, 2nd. The company reported ($0.20) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.10.

Synthetic Biologics's stock reverse split on Monday, July 25th 2022.The 1-10 reverse split was announced on Monday, July 25th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 25th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of SYN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Synthetic Biologics investors own include Tonix Pharmaceuticals (TNXP), Advanced Micro Devices (AMD), Synergy Pharmaceuticals (SGYP), Sorrento Therapeutics (SRNE), Vaxart (VXRT), Palatin Technologies (PTN) and Meta Platforms (META).

Company Calendar

Last Earnings
11/02/2021
Today
7/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:SYN
Employees
16
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.27 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$4.95 per share
Price / Book
N/A

Miscellaneous

Free Float
15,503,000
Market Cap
$16.16 million
Optionable
Not Optionable
Beta
1.38
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSEAMERICAN:SYN) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners